F. Hoffmann-La Roche Ltd: FDA approves Roche's Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
Evrysdi is the only non-invasive disease-modifying SMA treatment and is approved in over 100 countries Evrysdi tablet can be stored at room temperature and offers the same demonstrated efficacy and sa ...
Medindia1d
Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029 with 13.7% CAGR | MarketsandMarkets™.
The global Molecular Infectious Disease Testing market, valued at US$8.49 billion in 2023, is forecasted to grow at a robust CAGR of 13.7%, reaching US$9.37 billion in 2024 and an impressive US$17.78 ...
Antibiotics Market to Grow by USD 18.22 Billion (2025-2029), Driven by Rising Infectious Diseases, with AI Redefining the Market Landscape - Technavio
Report with market evolution powered by AI - The global antibiotics market size is estimated to grow by USD 18.22 billion ...
pharmaphorum5d
A history of Roche
We explore the history of global pharmaceutical group Hoffmann-La Roche from where it first began, to its core structure and its focus for the future in personalised medicine. Roche was found in ...
Genomic Data Analysis and Interpretation Market Research 2025-2033: Syngenta Group Leads, Followed by Amgen, Monsanto (Bayer), and Illumina
The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to 2033" report has been added to ...
PharmiWeb2d
In Vitro Diagnostics Market Size to Expand USD 129.14 Bn by 2033
The global in vitro diagnostics market size was reached at USD 83.41 billion in 2024 and is expected to expand around USD 129.14 billion by 2033, with a CAGR of 4.97% from 2024 to 2033. The market is ...
Global Xolair Market Outlook 2025-2034: Growth Drivers, Share, And Trends
The Business Research Company Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase is Your Competitive Edge Tod ...
Reawakening Dormant Nerve Cells: Groundbreaking Neurotechnology Restores Motor Function in SMA
A new electrical stimulation therapy for spinal muscle atrophy (SMA) has shown promise in reactivating motor neurons and ...